Yixiang sits on the board of Emergex, a biotech company developing T Cell Vaccine against CoVID-19.
Yixiang has 8 years’ experience working in finance management at Procter & Gamble and Sky. Prior to that, Yixiang worked in biomedical research for 6 years.
Follow us on social
Keep up to date with what's going on by following us on social media.